Corporate America now returns more cash to shareholders through buybacks than through dividends — hundreds of billions of dollars a year spent by companies buying their own stock. Buybacks are also one of the most argued-about mechanisms in markets, praised as efficient capital return and damned as EPS cosmetics. Both descriptions are sometimes true. Here is how the machine actually works, and how to tell which description fits a given company.
The mechanics
A buyback starts with the board authorizing a repurchase program — "up to $10 billion" — which is a permission, not a promise; plenty of authorizations go partly unused. The company then buys its own shares, overwhelmingly through ordinary open-market purchases spread over months (with occasional tender offers at a premium, or accelerated programs executed up front through a bank). Repurchased shares are retired or held in treasury; either way they stop counting.
The arithmetic consequence is the whole point: the company's earnings are now divided among fewer shares. A firm earning $10 billion across 10 billion shares posts $1.00 of EPS; retire a billion shares and the same $10 billion of profit prints $1.11. Earnings per share rose 11% while earnings rose zero. Nothing fraudulent occurred — each remaining share genuinely owns more of the company — but "EPS growth" and "profit growth" have quietly become different numbers, and every buyback-heavy company's headlines live in that gap.
The honest case for buybacks
- They return surplus cash without creating an obligation. Dividends behave like commitments — cutting one is a market event. Buybacks flex quietly with conditions, which is why managements prefer them for variable cash flows.
- They are tax-efficient capital return. A dividend taxes every holder today; a buyback delivers value as price appreciation, taxed only when a holder chooses to sell.
- At cheap prices, they compound beautifully. A company repurchasing genuinely undervalued shares transfers wealth from sellers to remaining holders. The great capital allocators — the kind tracked on our whales page — have repeatedly praised exactly this: opportunistic repurchase below intrinsic value.
The honest case against
- Companies are famously bad at timing them. Aggregate buyback volume has historically peaked near market tops — flush years produce buybacks at high prices — and dried up in crashes, when shares were cheapest but cash was scarce. Buying high and stopping low is the opposite of value creation.
- They can be EPS cosmetics. When executive pay targets EPS, repurchases hit the target without improving the business. A company shrinking its share count while revenue stalls is managing a ratio, not growing.
- They can mask dilution. Many firms issue shares continuously as stock compensation and buy them back with cash. The share count barely falls; the "return of capital" is substantially the payroll bill routed through the market. The tell is comparing gross buybacks to the actual change in diluted share count over several years.
- Debt-funded buybacks add fragility. Borrowing to retire equity juices per-share metrics in good times and stiffens the balance sheet against bad ones.
How to grade a buyback in five checks
- Is the share count actually falling? Pull up diluted shares outstanding over 3–5 years. Down meaningfully = real. Flat despite billions spent = compensation laundering.
- What price is being paid? Repurchases at modest valuations create value; repurchases at euphoric multiples transfer it to departing shareholders.
- What is it funded with? Surplus free cash flow is healthy; rising leverage for buybacks deserves skepticism.
- What is being starved? Capital returned is capital not invested. For a business with rich reinvestment opportunities, an aggressive buyback can signal a management out of ideas.
- EPS growth vs. net income growth. When the two diverge for years, the buyback is doing the work the business isn't — worth knowing before paying a growth multiple, and worth remembering each earnings season when "record EPS" headlines land.
The fair summary: a buyback is a capital-allocation tool with no inherent moral character. Executed opportunistically with surplus cash by a disciplined management, it is among the most shareholder-friendly acts a company can perform. Executed on autopilot at any price to flatter a bonus metric, it is expensive theater. The five checks above — all runnable from public filings and the numbers on any earnings page — tell you which movie you're watching.